The E156K mutation in the gene affects the epithelial-mesenchymal transition and migration of human lens epithelial cells.

PURPOSE

To investigated the biological effects of E156K-mutated αA-crystallin (CRYAA) in human lens epithelial cells (HLECs).

METHODS

FLAG-tagged, human, full-length, wild-type (WT), or E156K-mutated CRYAA was expressed in HLECs under knockdown. CRYAA expression was determined by quantitative reverse transcription polymerase chain reaction and western blotting (WB). Rhodamine cytoskeleton staining was used to observe the changes in cell morphology following transfection with WT or E156K-mutated plasmids. WB was performed to assess the expression of markers related to epithelial-mesenchymal transition (EMT) and migration.

RESULTS

Rhodamine cytoskeleton staining revealed changes in the morphology of cells transfected with E156K-mutated and opposite responses occurred after treatment with a β-catenin inhibitor. Cells transfected with E156K-mutated expressed remarkably higher levels of the mesenchymal biomarkers N-cadherin and vimentin but decreased levels of the epithelial biomarker E-cadherin, whereas opposite trends were observed in cells treated with the β-catenin inhibitor, ICG001. The migratory capability of E156K-mutated cells was significantly greater than that of WT cells ( < 0.001). This effect was accompanied by significantly increased expression levels of phosphorylated (p)-focal adhesion kinase (FAK) and -Src. These changes were decreased significantly by treatment with FAK and Src inhibitors.

CONCLUSION

E156K-mutated CRYAA induced EMT, in which the HLECs lost cell polarity, and acquired a mesenchymal phenotype with greater migratory capability. These biological effects may be associated with activation of the Wnt/β-Catenin and FAK/Src signaling pathways.